Date published: 
3 June 2020
Type: 
News
Intended audience: 
Health sector
NIP Schedule Changes 2020 image

From 1 July 2020 there will be changes to the immunisation schedule designed to improve protection against meningococcal and pneumococcal disease. 

The changes are being implemented following recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) and other clinical experts.

Changes to the NIP meningococcal vaccination schedule

The meningococcal B vaccine (Bexsero®) will be added to the NIP for Aboriginal and Torres Strait Islander infants at 2, 4, and 12 months of age.  An additional dose at 6 month of age is required for Aboriginal and Torres Strait Islander infants with specified medical risk conditions. 

Introduction of the vaccine will be supported by a catch-up program for all Aboriginal and Torres Strait Islander children aged under 2 years until 30 June 2023.

Meningococcal B and meningococcal ACWY vaccines will also be funded under the NIP for people of all ages with specified medical risk conditions that increase their risk of IMD.

Refer to the:

Changes to the NIP pneumococcal vaccination schedule

The recommendations regarding pneumococcal vaccination dosage and timing have been updated for adults and people with conditions that increase their risk of disease. There are no changes to the universal infant schedule for 13vPCV. The list of conditions that increase the risk of pneumococcal disease has also been revised and simplified.

Refer to the:

Changes to the NIP hepatitis A childhood vaccination schedule

To accommodate the introduction of meningococcal B vaccination for Aboriginal and Torres Strait Islander children on 1 July 2020, the hepatitis A vaccination schedule points (for children in NT, Qld, SA and WA) will also change.

Resources for vaccination providers

    ATAGI advice
      NIP schedules
      Meningococcal B consumer resources
      Tags: